share_log

Morgan Stanley Maintains Equal-Weight on Evelo Biosciences, Lowers Price Target to $4

Benzinga Real-time News ·  Sep 9, 2022 20:48

Morgan Stanley analyst Vikram Purohit maintains Evelo Biosciences (NASDAQ:EVLO) with a Equal-Weight and lowers the price target from $5 to $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment